Whoweare
Our team
Founded in 2015 and backed by global investors, we’ve built a 60-strong team in Oxford and a core portfolio of 50+ companies – with a pipeline of world-changing ventures still to come.
Our investors
We’re owned by global shareholders and supported by a network of specialist co-investors who invest alongside us from pre-seed to growth.
£
m
£
bn+
exits
£
bn+
STORIES
Professor Dame Carol Robinson: From lab assistant to biotech pioneer
Her career path may be unconventional, but Dame Carol’s talent and tenacity has paved the way for a revolution in drug discovery.
She left school in 1972 with few qualifications, but that didn’t stop her going on to become one of the world’s most decorated scientists.
Not only is Dame Carol the first woman to hold a full professorship in Chemistry at both Oxford and Cambridge universities, she’s also the founder of OMass Therapeutics, a trailblazing OSE portfolio company in the biotech sector.
The company builds on Dame Carol’s pioneering work in ‘native mass spectrometry’ – a technique for studying proteins in their natural state. The technique has revolutionised structural biology and paved the way for breakthroughs in small drug discovery.
Founder, OMass Therapeutics
WORK WITH US
Oxford researchers & innovators
Want your research to have real-world impact?
We partner with researchers and innovators across Oxford, Harwell and Culham to explore commercial potential, co-create ventures and build companies.
Investors
Interested in becoming an OSE shareholder?
We’ve raised over £850m from global investors keen to access Oxford’s diverse, world-leading science. Our shareholders don’t just back OSE – many also co-invest alongside us.
Co-investors
Looking to invest in Oxford’s most exciting spinouts?
We partner with specialist global investors to fund and scale our companies – from pre-seed to growth. Together, OSE and our co-investors have invested more than £3bn.